Lymphomas
A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study (PCI-32765CAN3001)
- Details
ClinicalTrials.gov ID:
NCT01804686
Diagnosis Type:
NA
USOR Number:
- Address
,
P: